CARDIOGENIC SHOCK DUE TO ACUTE MYOCARDIAL INFARCTION
Clinical trials for CARDIOGENIC SHOCK DUE TO ACUTE MYOCARDIAL INFARCTION explained in plain language.
Never miss a new study
Get alerted when new CARDIOGENIC SHOCK DUE TO ACUTE MYOCARDIAL INFARCTION trials appear
Sign up with your email to follow new studies for CARDIOGENIC SHOCK DUE TO ACUTE MYOCARDIAL INFARCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Rapid heart pump upgrade may save lives in shock
Disease control Recruiting nowThis study tests whether quickly upgrading from a standard heart pump (Impella CP) to a more powerful one (Impella 5.5) within 24 hours after a heart attack improves outcomes for people in cardiogenic shock. The trial will enroll 115 adults aged 18-77 who have had a heart attack …
Matched conditions: CARDIOGENIC SHOCK DUE TO ACUTE MYOCARDIAL INFARCTION
Sponsor: University Hospital of Cologne • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could less blood pressure medicine save more lives in heart shock?
Disease control Recruiting nowThis study tests whether using less of the drug noradrenaline, by aiming for a lower blood pressure target (55 mmHg instead of 65 mmHg), can improve survival and reduce severe kidney failure in people with cardiogenic shock after a heart attack. About 776 adults will be randomly …
Matched conditions: CARDIOGENIC SHOCK DUE TO ACUTE MYOCARDIAL INFARCTION
Phase: PHASE4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC